This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Piper Sandler analyst Kelsey Goodwin downgraded Tango Therapeutics Inc (NASDAQ:TNGX) from Overweight to Neutral and raised the price target from $16 to $24. Tango Therapeutics shares closed at $24.87 on Thursday. See how other analysts view this stock.
• Morgan Stanley analyst Stephen Grambling downgraded Viking Holdings Ltd (NYSE:VIK) from Overweight to Equal-Weight and raised the price target from $81 to $86. Viking Holdings shares closed at $86.72 on Thursday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Mitchell S. Kapoor downgraded Alumis Inc (NASDAQ:ALMS) from Buy to Neutral and maintained the price target from $25 to $25. Alumis shares closed at $24.63 on Thursday. See how other analysts view this stock.
• Morgan Stanley analyst Michael Ulz downgraded Aardvark Therapeutics Inc (NASDAQ:AARD) from Equal-Weight to Underweight and cut the price target from $7 to $3. Aardvark Therapeutics shares closed at $6.73 on Thursday. See how other analysts view this stock.
• JP Morgan analyst Tomohiko Sano downgraded A O Smith Corp (NYSE:AOS) from Neutral to Underweight and lowered the price target from $65 to $60. A.O. Smith shares closed at $57.97 on Thursday. See how other analysts view this stock.

Considering buying ALMS stock? Here’s what analysts think:

Photo via Shutterstock